AW
NVCT icon

Avion Wealth’s Nuvectis Pharma NVCT Stock Holding History

Avion Wealth’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-56
Closed – – 1434
2025
Q2 		$0 Buy
+56
New +$508 ﹤0.01% 1469

Other funds holding NVCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Avion Wealth's NVCT Position: Q3 2025 in Review

Avion Wealth sold out of Nuvectis Pharma (NVCT) in Q3 2025, closing a stake of 56 shares.

Avion Wealth first reported a position in NVCT in Q2 2025 and held it in 1 quarter. The position peaked at $0 in Q2 2025. 53 funds tracked by Wall St. Rank hold NVCT as of Q3 2025.

  • Avion Wealth reported no remaining Nuvectis Pharma position as of Q3 2025 after selling out during the quarter.
  • Avion Wealth sold 56 Nuvectis Pharma shares in Q3 2025.
  • Avion Wealth first reported a position in Nuvectis Pharma in Q2 2025 and held it in 1 quarter.
  • Avion Wealth's Nuvectis Pharma position peaked at $0 in Q2 2025.
  • 53 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2025.

Based on Avion Wealth's 13F filing for Q3 2025, filed 24 Oct 2025.